Hanmi Science

Real estate Warburg Pincus-Wide Creek Asset JV picks up 2nd Korean logistics asset

US private equity firm Warburg Pincus LLC and South Korean real estate manager Wide Creek Asset Management Co. are building a logistics center for l...

Electronics Hanmi Semiconductor to retire $90 mn treasury shares in May

Hanmi Semiconductor Co. on Thursday announced a plan to retire 130.0 billion won ($90 million) worth of treasury shares in May, marking its largest-...

Electronics Hanmi Semiconductor to build new TC Bonder plant in Incheon

Hanmi Semiconductor Co., South Korea’s leading chip packaging equipment manufacturer, held a ground-breaking ceremony for its seventh plant of...

Corporate governance Hanmi Pharm’s chair poised to win management feud with her son

Hanmi Pharmaceutical Group Chairman Song Young-sook is poised to claim victory in a year-long dispute with her eldest son Lim Jong-yoon to take cont...

Bio & Pharma Hanmi breaks ground pharmaceuticals complex in Beijing

South Korea's Hanmi Pharmaceutical Co. said on Friday that Beijing Hanmi Pharm, its subsidiary in China, held the groundbreaking ceremony for a proj...

Private equity La Defense might have a say over Hanmi Pharm's family feud

La Defense Partners is expected to exercise a casting vote over the ongoing management dispute at Hanmi Science Co. after the Seoul-based private eq...

Bio & Pharma Hanmi Pharma to move up launch of anti-obesity drug

South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...

Banking & Finance Hanmi Bank rises from Koreatown lender to regional bank

It began in 1982 as a small community bank for Korean immigrants in Los Angeles, California. Today, Hanmi Bank, under Nasdaq-listed Hanmi Financial ...

Electronics LG NOVA hosts Innovation Festival in US

LG Electronics Inc. 's North American Innovation Center (LG NOVA) said on Monday that it held an Innovation Festival last Wednesday and Thursday at ...

Pension funds NPS signals more say in Hanmi Pharmaceutical's family feud

South Korea’s National Pension Service is indicating more active involvement in the management of Hanmi Pharmaceutical Group embroiled in a ye...

Corporate governance Korea’s Hanmi family feud to end as key shareholder mediates

South Korean Hanmi Pharmaceutical Group’s founding family is set to conclude an ongoing feud as the group’s top individual shareholder h...

Korean chipmakers Hanmi Semiconductor eyes $1.5 billion sales in 2026

Hanmi Semiconductor Co., South Korea’s leading chip packaging equipment manufacturer, has revised upwards its annual sales target for this yea...

Korean chipmakers Booming AI industry boosts chip packaging equipment makers

Global chip packaging equipment manufacturers are enjoying surging demand and skyrocketing share prices thanks to the rapid growth of the artificial...

Korean chipmakers Hanmi Semiconductor wins $110 mn HBM equipment order from SK Hynix

South Korean chip equipment company Hanmi Semiconductor Co. announced on Friday that it has received an order from SK Hynix Inc. for its dual TC bon...

Corporate governance Hanmi to fire founder's wife, entering new round of family feud

South Korea’s Hanmi Pharmaceutical Group is set to enter a new chapter of an ongoing family feud less than two months after the founding famil...

Bio & Pharma Samsung Life Science invests in US biotech firm Latus Bio

Samsung Life Science Fund, managed by Samsung Group’s venture investment arm, has invested in US biotechnology firm Latus Bio Inc. during the ...

Bio & Pharma KKR, Hanmi heirs likely to join hands for controlling stake

The two sons of Hanmi Pharmaceutical Group’s founding family, who were approved as board members of the holding firm Hanmi Science Co. at its ...

Mergers & Acquisitions Hanmi’s planned merger with OCI scrapped as sons win family feud

Hanmi Pharmaceutical Group’s proposed merger with OCI Holdings Co. has collapsed after two sons of the group’s founding family, who oppo...

Corporate governance Hanmi Science-OCI merger may gain traction with NPS' support

The merger of South Korea’s pharmaceutical holding firm Hanmi Science Co. and chemicals giant OCI Holdings Co. is likely to gain momentum as N...

Insurance KIDI to build insurance infrastructure in Vietnam

The Korea Insurance Development Institute (KIDI) announced on Friday that it signed a business agreement with the Vietnam Insurance Development Inst...

Korean chipmakers Hanmi Semiconductor wins $16 mn HBM equipment order from SK Hynix

South Korean chip equipment company Hanmi Semiconductor Co. announced on Friday that it has secured a 21.5 billion won ($16.1 million) supply deal f...

Mergers & Acquisitions Proxy advisor KCGS backs Hanmi founder's sons return to board

South Korea’s top proxy advisory firm has recommended that shareholders of Hanmi Science Co. vote in favor of Hanmi Pharmaceutical Group&rsquo...

Bio & Pharma Samsung invests in BrickBio in US

Samsung Group announced on Tuesday that its Life Science Fund has invested in the US-based antibody-drug conjugates (ADC) and gene therapy technol...

Automobiles IL Science enters UK silicon lens market

South Korea's IL Science Co. said on Monday that it signed a contract with the US-based automotive electronics company Polymer Optics to supply an i...

Bio & Pharma Samsung targets gene therapy sector through US investments

Samsung Group is targeting the gene therapy business through investments in US biotechnology companies as the leading South Korean conglomerate is s...

Mergers & Acquisitions OCI-Hanmi merger faces tougher hurdles amid family feud

Hanmi Pharmaceutical Group’s aim to merge with chemicals giant OCI Group is hitting some roadblocks amid a prolonged feud between the family o...

Mergers & Acquisitions OCI-Hanmi merger to create Korea’s Bayer: OCI Chairman

Merging into one team, OCI Group and Hanmi Pharmaceutical Group will leap forward to be a global novel drug manufacturing and biotechnology innova...

Bio & Pharma Samsung eyes biotech investments via Flagship Pioneering

Samsung C&T Corp., Samsung Biologics Co. and Samsung Bioepis Co. will ramp up investments in US biotechnology startups in collaboration with Fla...

Bio & Pharma Samsung Engineering secures $349 mn bio plant deal

South Korea's Samsung Engineering secured a deal for the Songdo Bio Raw Material Plant construction project from the global life sciences and labora...

Bio & Pharma Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved

South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...